Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.
about
Interleukin-1 Family Cytokines in Liver DiseasesEpithelial IL-18 Equilibrium Controls Barrier Function in Colitis.The impact of ATRA on shaping human myeloid cell responses to epithelial cell-derived stimuli and on T-lymphocyte polarizationBone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.IL-33 activates tumor stroma to promote intestinal polyposis.Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.Reparative inflammation takes charge of tissue regeneration.A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.Infliximab does not increase colonic cancer risk associated to murine chronic colitis.Positive selection of IL-33 in adaptive immunity of domestic Chinese goats.Cytokines and mucosal immunity.Role of inflammasomes in intestinal inflammation and Crohn's disease.Interleukin 33 is a guardian of barriers and a local alarmin.Selected cytokine pathways in rheumatoid arthritis.Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome.Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.The epithelial barrier and immunoglobulin A system in allergy.Tuberculosis-sensitized monocytes sustain immune response of interleukin-37.The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116.Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice.A Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis.Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure.IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer.Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis.Interleukin(IL)-36α and IL-36γ Induce Proinflammatory Mediators from Human Colonic Subepithelial Myofibroblasts.Ligands and receptors of the interleukin-1 family in immunity and disease.The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.Interleukin-18: Biological properties and role in disease pathogenesis.Toll-like Receptors and Inflammatory Bowel Disease.Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.IL-36α suppresses proliferation of ovarian cancer cells.Interleukin-37: A Peacekeeper at the Intestinal Borders.Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2.IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis.Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.A cytokine network involving IL-36γ, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage.Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory TractsIL-33/ST2 Axis in Organ FibrosisAnakinra Therapy for Non-cancer Inflammatory Diseases
P2860
Q26778553-B673FDEA-B85E-4E40-9993-DBCF4A15C6FEQ27321681-A0B2FA72-7CEB-4F88-B34D-04C4D8631D65Q35508697-9E4630C0-0312-4174-977D-9DCBC11287DBQ35614331-0AD3A24B-DBA1-48B8-BDEB-27DB813D2EA3Q35616286-FDD2515A-0308-43F8-88B1-C05F4C309162Q35896724-3C223ACE-E6E8-46AC-B75E-D6107341B6ADQ35899475-61E4F4DD-E870-4E52-ACB2-62AFE2985110Q37242384-66F28E77-3D97-47B8-9EE1-04FB6BFF0428Q37444240-1CC3148C-9C93-4FEC-B9FA-4A6D8A9BC06CQ37706803-605CE06F-DEB4-47F4-9AC1-0896342AA511Q38247384-1A2A1D02-C1F0-4953-849B-E8227BB5DA02Q38291767-6CC5BF04-EF01-41BF-9950-A702B342152AQ38702558-E54F1B79-45C4-4E06-BC1E-0789D7F361AAQ38755912-E8F84F4B-A9C4-4B65-89CB-06EEC55B8035Q38795315-84EC0FCB-8B7E-49F6-86F6-858F890C498BQ38804875-404D70FF-0DA4-412F-A471-1FC158703A25Q38809309-06630CE0-8732-48E9-8896-B42E8C15DA30Q38967737-C24F923D-FF66-4F93-98C8-BAB3DDBF83E7Q39334761-0C87EDAF-B1A5-40EF-9E53-AE76165F95B7Q40373066-5D0D7F20-6CCC-407B-B9CC-2E36DA6E2179Q41019883-DD470A72-709D-4116-A731-931D2C2C0E21Q41523753-738127CB-3500-4174-8A34-63046E531C2AQ41785739-3B4FC2B8-BD34-42CA-98E9-B124661713D0Q41903813-D2A915BD-AA28-477F-9D8E-2CEC227CDF45Q42046295-3999A99A-F087-453A-8B50-2C0D548AE659Q42077731-B48F105F-C057-41F2-926F-2285BE20854DQ42876488-BFFDB6D8-D904-4F5C-AB9A-35575CA4DE69Q47109861-E6AEB7B1-BED7-403B-BD54-C4927F348CAAQ47285927-29366CE2-2402-4070-9512-83F45163461BQ49416505-704F054F-73C9-4FA5-BACC-BE2CF788900FQ49981026-CEEB6899-5A6A-42E5-9424-683B479C0BDAQ50941305-86EFAC4C-4ED4-4C0F-8833-E62E1BC4B186Q51099966-7215425D-6182-4635-AA25-98CFA7E55D0BQ51221296-F36EE156-B6FD-4255-AF57-CBDC3542CDC1Q51704712-866A4A40-3C69-444D-B75D-75F50EB83636Q54182052-277E42FB-0790-4D31-9121-59625239BB59Q54212214-472AF8D7-C794-41D9-9C17-E36440406F53Q57492032-9B27BBF4-C961-46EF-9523-401DF334D396Q58566658-1899CBA2-7A7A-4497-A314-569A8AC3423BQ59136398-0B0AC1B2-1CE5-40D6-8263-ECA728B24B04
P2860
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.
@en
type
label
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.
@en
prefLabel
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.
@en
P2093
P2860
P356
P1476
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.
@en
P2093
Loris R Lopetuso
Saleem Chowdhry
Theresa T Pizarro
P2860
P356
10.3389/FIMMU.2013.00181
P577
2013-07-09T00:00:00Z